Page 1 of Clinical Trials for salmeterol fluticasone propionate, 181 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Last Updated: May 10, 2012
Condition(s): Asthma
2
Completed
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Last Updated: February 24, 2010
Condition(s): Asthma
3
Recruiting
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Last Updated: May 10, 2012
Condition(s): Asthma
4
Completed
Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: March 15, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
5
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Last Updated: June 16, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
6
Completed
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Last Updated: March 17, 2011
Condition(s): Asthma
7
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Last Updated: August 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
8
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: May 17, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
9
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
Last Updated: May 5, 2011
Condition(s): Asthma
10
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
Last Updated: November 10, 2011
Condition(s): Asthma
11
Active, not recruiting
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Last Updated: February 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
12
Completed
Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy
Last Updated: July 28, 2011
Condition(s): Asthma
13
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
14
Terminated
ADVAIR DISKUS (Fluticasone Propionate/Salmeterol) Versus SEREVENT DISKUS (Salmeterol) On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease
Last Updated: October 1, 2010
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
15
Completed
Fall Epidemic Viral Pediatric Study
Last Updated: November 17, 2011
Condition(s): Asthma
16
Completed
Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations
Last Updated: September 15, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
17
Completed
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
Last Updated: November 23, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
18
Completed
Advair® DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS® (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations
Last Updated: March 17, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Airway Disease
19
Recruiting
Pharmacogenetics of b2-Agonists in Asthma.
Last Updated: September 8, 2011
Condition(s): Asthma
20
Active, not recruiting
Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients
Last Updated: September 8, 2011
Condition(s): Asthma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=salmeterol+fluticasone+propionate

Page 1 of Clinical Trials for salmeterol fluticasone propionate, 181 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About